National Framework Agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disorders
NHS framework agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disorders. The framework will commence on 1.2.2018 for a period of 12 months until 31.1.2019 with options to extend up to a further 17 months.
Buyer
NHS England
Value
£302,000,000
Published
19 Dec 2017
Closes
22 Sept 2017
Procurement details
Source
Contracts Finder
Region
London
Procurement method
Open
Category
Goods
Contract starts
1 Feb 2018
Contract ends
31 Jan 2019
CPV classifications
33141530
Blood coagulants
Lots
Lot default National Framework Agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disorders
£302,000,000
NHS framework agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disorders. The framework will commence on 1.2.2018 for a period of 12 months until 31.1.2019 with options to extend up to a further 17 months.
Delivery: British Oversea Territories, Channel Islands, East Midlands · United Kingdom, East of England · United Kingdom, Europe, Guernsey
Documents
Unlock document linkOpportunity notice on Contracts Finder
22 Aug 2017
Opportunity notice on Contracts Finder
Tender notice · Web page
OJEU Notice
Not provided
OJEU Notice
Tender notice
n/a
Not provided
n/a
Tender notice · Word document
n/a
Not provided
n/a
Tender notice · Word document
n/a
Not provided
n/a
Tender notice · Word document
n/a
Not provided
n/a
Tender notice · Word document
n/a
Not provided
n/a
Tender notice · Word document
n/a
Not provided
n/a
Tender notice · Excel spreadsheet
n/a
Not provided
n/a
Tender notice · Excel spreadsheet
n/a
Not provided
n/a
Tender notice · Excel spreadsheet
n/a
Not provided
n/a
Tender notice · File
n/a
Not provided
n/a
Tender notice · Word document
Contains public sector information licensed under the Open Government Licence v3.0.